| Thymic expression of IL-4 and IL-15 after systemic inflammatory or infectious Th1 disease processes induce the acquisition of" innate" characteristics during CD8+ T cell … NS Baez, F Cerbán, C Savid-Frontera, DL Hodge, J Tosello, ... PLoS pathogens 15 (1), e1007456, 2019 | 26 | 2019 |
| Exploring the immunomodulatory role of virtual memory CD8+ T cells: Role of IFN gamma in tumor growth control C Savid-Frontera, ME Viano, NS Baez, NL Lidon, Q Fontaine, HA Young, ... Frontiers in Immunology 13, 971001, 2022 | 10 | 2022 |
| Human effectors of acute and chronic GVHD overexpress CD83 and predict mortality SG Holtan, C Savid-Frontera, K Walton, AA Eaton, C Demorest, ... Clinical Cancer Research 29 (6), 1114-1124, 2023 | 7 | 2023 |
| Virtual Memory CD8+ T Cells: Origin and Beyond ME Viano, NS Baez, C Savid-Frontera, NL Lidon, DL Hodge, A Herbelin, ... Journal of Interferon & Cytokine Research 42 (12), 624-642, 2022 | 6 | 2022 |
| Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic C Savid-Frontera, ME Viano, NS Baez, D Reynolds, M Matellon, ... Immunotherapy 14 (2), 115-133, 2022 | 3 | 2022 |
| Paired Analysis from Patients with Myeloma Elucidates Favorable CAR-T Manufacture and Phenotype, Starting from Mobilized Pre-Transplant Apheresis Vs. Non-Mobilized Apheresis … CLL Freeman, JA Miranda, M Menges, J Noble, H Liu, S Corallo, ... Blood 142, 1931, 2023 | 1 | 2023 |
| Systemic inflammatory Th1 cytokines during Trypanosoma cruzi infection disrupt the typical anatomical cell distribution and phenotypic/functional characteristics of various … ME Viano, NS Baez, C Savid-Frontera, RE Baigorri, B Dinatale, MF Pacini, ... Microbes and Infection, 105337, 2024 | | 2024 |
| CD19 Intron Retention Is Mechanism of CAR-T Treatment Resistance in Non-Hodgkin Lymphoma J Noble, FL Locke, C Savid-Frontera, MD Jain, JG Turner, JA Miranda, ... Blood 142, 3506, 2023 | | 2023 |
| A Novel IL2Rα-/-Model for CAR-T Toxicity in Acute Lymphoblastic Leukemia Recapitulates Cytokine Release Syndrome and Neutropenia P Goala, H Kotani, Z Yongliang, KM Reid, JC Boucher, C Savid-Frontera, ... Blood 140 (Supplement 1), 1176-1177, 2022 | | 2022 |
| PARTICIPACIÓN EN CONGRESOS CS FRONTERA, N BAEZ Bioq. Constanza Savid-Frontera Directora: Dra. María Cecilia Rodríguez-Galán …, 2020 | | 2020 |
| TÉCNICAS GENERALES PURIFICACIÓN DE PLÁSMIDOS LIBRES DE ENDOTOXINA C DE FLUJO Bioq. Constanza Savid-Frontera Directora: Dra. María Cecilia Rodríguez-Galán …, 2020 | | 2020 |
| PUBLICACIONES EN REVISTAS CON REFERATO C Savid-Frontera, NS Baez, D Reynolds, MC Rodriguez-Galan, F Cerbán, ... Bioq. Constanza Savid-Frontera Directora: Dra. María Cecilia Rodríguez-Galán …, 2020 | | 2020 |
| Estudio y caracterización de células T CD8+ innatas como posibles mediadores terapéuticos en cáncer C Savid Frontera | | |
